Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Kif15-IN-2 is used for the research of cellular proliferative diseases. Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約8-10 週間 | ¥ 45,500 |
5 mg | 約8-10 週間 | ¥ 80,000 |
25 mg | 約8-10 週間 | ¥ 262,000 |
50 mg | 約8-10 週間 | ¥ 342,000 |
100 mg | 約8-10 週間 | ¥ 457,000 |
1 mL * 10 mM (in DMSO) | 約8-10 週間 | ¥ 88,000 |
In vitro | Kif15-IN-2, a mitotic kinesin Hs Kif15 inhibitor, displays potential therapeutic activities against various cellular proliferative diseases, including cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders, and inflammation. |
分子量 | 440.48 |
分子式 | C20H20N6O4S |
CAS No. | 672926-33-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (45.41 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Kif15-IN-2 672926-33-9 Others Kif15IN2 Kif-15-IN-2 Kif15 IN 2 Inhibitor inhibitor inhibit